Amanta Healthcare Limited Share Price & Stock Analysis

Amanta Healthcare Limited (NSE: AMANTA, BSE: 544502) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹761 Cr, it ranks #1,746 by market cap among the 6,197 Indian listed companies on FinBizNet, and #25 of 63 in Pharmaceuticals. At ₹233.22 (as of 16 Nov 2026), the share price is 3.6% below its 52-week high of ₹241.89 and 145.4% above its 52-week low of ₹95.03. The share price is up 95.2% over one year and up 53.0% over three months.

Key Metrics

Current Price₹233.22
Market Cap₹761 Cr
NSE SymbolAMANTA
BSE Code544502
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio52.4
Return on Equity6.76%
Return on Assets5.50%
52-Week Range₹95.03 – ₹241.89
1-Year Price Change+95.2%
3-Month Price Change+53.0%
Beta (1Y)0.17
HeadquartersAhmedabad, Gujarat
Websitewww.amanta.co.in

Latest Quarterly Results — Q2 FY27

Revenue₹83 Cr
Net Profit₹5 Cr
Net Margin5.8%
EPS (Basic)₹1.25
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Amanta Healthcare Limited Quarterly Revenue and Profit Trend

Amanta Healthcare Limited reported revenue of ₹83 Cr in Q2 FY27, up 17.3% from ₹71 Cr in Q2 FY26 and up 20.8% from ₹69 Cr in Q1 FY27. It posted a net profit of ₹5 Cr for the quarter, against a net profit of ₹1 Cr in Q2 FY26 (up 301.7%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹65 Cr (Q1 FY26) to ₹83 Cr (Q2 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹83 Cr₹5 Cr5.8%
Q1 FY27₹69 Cr₹3 Cr4.8%
Q4 FY26₹77 Cr₹6 Cr7.2%
Q3 FY26₹74 Cr₹5 Cr6.2%
Q2 FY26₹71 Cr₹1 Cr1.7%
Q1 FY26₹65 Cr₹4 Cr5.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 63.80% of Amanta Healthcare Limited's shares as of Sept 2026, against 63.56% in Sept 2025 (+0.24 percentage points). Delivery averaged 45.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Amanta Healthcare Limited

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering wit

Products and Services

1. Manufacturing and sale of pharmaceutical products-This segment engages in the development, manufacture, and marketing of various sterile liquid parenteral products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Manufacturing and sale of pharmaceutical products-100%

Amanta Healthcare Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Amanta Healthcare Limited₹761 Cr52.46.76%₹83 Cr+95.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Amanta Healthcare Limited?

Amanta Healthcare Limited is trading at ₹233.22, with a market capitalisation of ₹761 Cr.

Which sector does Amanta Healthcare Limited belong to?

Amanta Healthcare Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Amanta Healthcare Limited?

Amanta Healthcare Limited has a P/E of 52.4 and a return on equity of 6.76%.

What is the stock symbol of Amanta Healthcare Limited?

Amanta Healthcare Limited is listed on the NSE under the symbol AMANTA and on the BSE under the scrip code 544502.

How has Amanta Healthcare Limited's share price moved over the past year?

Amanta Healthcare Limited's share price is up 95.2% over one year and up 53.0% over three months. Its 52-week range is ₹95.03 to ₹241.89.

What were Amanta Healthcare Limited's latest quarterly results?

In Q2 FY27, Amanta Healthcare Limited reported revenue of ₹83 Cr and net profit of ₹5 Cr, with basic EPS of ₹1.25 (standalone, parsed from the company's exchange filing).

How have Amanta Healthcare Limited's revenue and profit changed over the past year?

Amanta Healthcare Limited reported revenue of ₹83 Cr in Q2 FY27, up 17.3% from ₹71 Cr in Q2 FY26 and up 20.8% from ₹69 Cr in Q1 FY27.

What is the promoter holding in Amanta Healthcare Limited?

Promoters held 63.80% of Amanta Healthcare Limited's shares as of Sept 2026, against 63.56% in Sept 2025 (+0.24 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.